Understanding Value in a Consumer- Oriented, Patient

Understanding Value in a ConsumerOriented, Patient-Centric Era
An Executive Roundtable Discussion
Thursday, October 15, 2015 | New York, NY USA
Understanding Healthcare Value in a
Consumer-Oriented, Patient-Centric Era
Thursday, October 15, 2015
1:00 - 5:00PM EST
New York, NY 10173
PRESENTED BY
Center for Healthcare Innovation
What Does Patient-Centric Healthcare Value Mean?
The Understanding Value in a Consumer-Oriented, Patient-Centric
Era is an exclusive, intimate Roundtable Discussion that brings together the top thought-leaders, visionaries, and executives from the
patient advocate, provider, payer, pharma, and pharmacy sectors to
discuss and increase understanding of what patient-centric
healthcare value means in the 21st century.
The healthcare landscape has rapidly shifted towards a consumer,
patient-centric model of care delivery. Today’s patients have become more empowered in their health and well-being, better in-
formed, and more financially invested than ever before. This paradigm shift has had dramatic implications not only for patients, but
also for providers, pharma, and payers as these latter groups attempt to define and deliver patient-centric healthcare value. Furthermore, the Roundtable explores the relationship between the definition of value and quality, access, and cost issues. As healthcare
costs continue to rise, capitation payment models become the new
norm, and incentives shift as a result of moving to a value-based
healthcare system. Understanding and integrating patient-centricity
into healthcare value will become more important than ever.
This consumer-focused Roundtable Discussion brings the best and
brightest healthcare leaders from around the globe together to
share their ideas and expertise on the intersection of healthcare value and patient-centricity.
Or contact us at www.chisite.org/contact
222 S. Riverside Plaza (Suite 1900)
|
Chicago, IL 60606
|
chisite.org
|
[email protected]
CHI is an independent, 501(c)(3) research and
educational institute that helps patients and
providers increase their knowledge and understanding of the opportunities and challenges of maximizing healthcare value to
improve health and quality of life. We aim to
make the world a healthier place.
CHI
encourages and enables meaningful and
executable innovation that aims to address
existing and ensuing healthcare dynamics
through communication, education, training,
symposia, reports, and research. By bringing
the best and brightest healthcare leaders
from all over the world together to share their
ideas and expertise, CHI creates a unique
opportunity to address and improve
healthcare value, which we view as a function
of quality, access, and cost.
Agenda
1:00PM
Registration & Networking
1:30PM
Opening Remarks
1:45PM
1st Roundtable Session on Cost & Value
Moderator: Mr. Dennis Urbaniak
3:00PM
Coffee Break & Networking
3:30PM
2nd Roundtable Session on Quality, Access, & Value
Moderator: Mr. Rob Wright
3 Understanding Healthcare Value in a Consumer-Oriented, Patient-Centric Era Roundtable
Co-Moderators
Mr. Dennis Urbaniak is a Managing Director at Accenture. He is
a life science and healthcare executive with demonstrated leadership
in driving innovative, customer-centric approaches that result in tangible business results.
His specialties include population health, patient services, change
management, innovation process, executive leadership, customer
centric marketing and sales, performance management.
Mr. Dennis Urbaniak,
Managing Director,
Accenture
Understanding Healthcare Value in a Consumer-Oriented, Patient-Centric Era Roundtable 4
Co-Moderators
Mr. Rob Wright, Chief
Editor, Life Science
Leader magazine
Mr. Rob Wright is the Chief Editor of Life Science Leader magazine. Prior to joining the publication in this role in 2010, Wright spent
nearly 20 years in the pharmaceutical industry. His experience with
such companies as Mead Johnson Nutritionals (formerly a division of
Bristol-Myers Squibb), Organon Pharmaceuticals, Schering-Plough
and Merck helps him to provide his readers with credible insights.
During his industry career, Wright conducted well over 1,000 presentations and roundtable discussions, including the facilitation of FDAmandated clinical training programs for hundreds of licensed
healthcare providers. He has chaired, co-chaired, moderated and
served as a speaker at industry and academic conferences. Wright’s
100+ published articles have appeared in peer-reviewed academic
journals, B2B magazines and online publications. He received a
Bachelor of Science (B.S.) in Business Administration from Indiana
University of Pennsylvania, Indiana, PA, and a Master of Business
Administration (MBA) with distinction from Gannon University, Erie,
PA. He completed his doctoral coursework in marketing at Cleveland
State University, Cleveland, OH. During his academic career he was
selected as a member of Sigma Beta Delta (International Honor Society for Business, Management, and Administration) and Beta Gamma Sigma (International Honor Society for AACSB accredited business program).
Understanding Healthcare Value in a Consumer-Oriented, Patient-Centric Era Roundtable 5
Roundtable Chairman
Dr. James J. Gillespie,
PhD, JD, MPA, CEO,
Center for Healthcare
Innovation
Dr. James J. Gillespie is CEO of the Center for Healthcare Innovation (www.chisite.org), a 501(c)(3) research center and thoughtleadership institution focusing on the global life sciences industry. He
is a scholar, executive, and entrepreneur, with an expertise focusing
on the strategy, analytics, and operations of the biotechnology, medical device, and pharmaceutical sectors. Dr. Gillespie is CEO and
Managing Director of the Chicago Life Sciences Consortium, a resource for early and middle stage biotechnology, medical device, and
healthcare companies in the metropolitan Chicago area. He is
Founder & Co-Leader of the Working Group on Innovation & Interoperability (WGII), a healthcare analytics project featuring executives
from Blue Cross Blue Shield Association, Computer Sciences Corporation (CSC), Healthcare Information and Management Systems Society (HIMSS), Metropolitan Chicago Healthcare Council (MCHC),
and Walgreens Corporation (WAGS). The WGII aims to leverage
large claims, clinical, & prescription databases for high-powered analytics to improve healthcare quality, access, and outcomes.
Dr. Gillespie serves as President and Co-Founder of the National
Biotechnology & Pharmaceutical Association (the leading professional organization for African-Americans in the life sciences industry),
President and Co-Founder of the National Hispanic Life Sciences
Society (the leading professional organization for Hispanic/LatinoAmericans in the life sciences industry), and Chairperson of the
Board of Directors of Women In Healthcare & Life Sciences (a
thought-leadership institution focused on increasing the number and
the quality of female executives, entrepreneurs, investors, and researchers/scientists in the global healthcare and life science sectors).
Dr. Gillespie chairs the annual symposium “Globalization of Innovation: China, India, and US Life Science Markets” hosted by Microsoft
Corporation and co-sponsored by Pharmaceutical Executive Magazine. He founded and chairs the annual symposium “Diversity, Inclusion, & Life Sciences”, which has become the world’s #1 annual
event focused specifically on the interface between diversity, inclusion, and the global life sciences industry.
Dr. Gillespie’s research has appeared in Academy of Management
Review, American Behavioral Scientist, European Journal of Social
Psychology, Federal Reserve Bank, Harvard Business Review, and
Strategic Management Journal. His education includes Northwestern
University Kellogg School of Management, M.A., Ph.D.; Harvard University School of Law, J.D.; Princeton University Woodrow Wilson
School of Public Policy, M.P.A.; Massachusetts Institute of Technology, B.S.; and Carnegie Mellon University.
6 Understanding Healthcare Value in a Consumer-Oriented, Patient-Centric Era Roundtable
Executive Participants
Mr. Jerry Beyl
Vice President of Healthcare Sales
FedEx
Mr. Matt Portch
Senior Director, Commercial Effectiveness,
Pfizer
Dr. Kristine Bordenave, MD
Lead Medical Director
Humana
Dr. Koustubh Ranade
Senior Researcher
MedImmune
Mr. David Frazer
Chief Executive Officer
Pediatric Cancer Foundation
Dr. Roslyn F. Schneider, MD, MSc
Global Patient Affairs Lead
Pfizer
Dr. Eric Floyd, PhD, MBA
Chief Scientific Officer
Dohmen Life Science Services
Dr. Stuart Sowder, PharmD, MBA, JD
Vice President, External Medical
Communications
Pfizer
Dr. James Gillespie, PhD, JD, MPA
Chief Executive Officer
Center for Healthcare Innovation
Ms. Lynn Hanessian
Chief Science Strategist
Edelman
Dr. Rivka Kreitman, PhD
Head of Search Evaluation and Alliance
Management
Teva Pharmaceuticals
Dr. Ari Levy, MD, MBA
Chief Executive Officer
Engaged Health Solutions
Mr. Jeffrey Marrazzo, MPA, MBA
Co-Founder and CEO
Spark Therapeutics
Dr. Cornell Stamoran
Vice President, Strategy & Government Affairs
Catalent Pharma Solutions
Mr. Douglas Swill, JD
Chair of Health Care Practice Group
Drinker Biddle
Dr. Eckhard von Keutz
Senior Vice President, Head Global
Early Development
Bayer Healthcare
Mr. Don Woodlock
Senior Vice President and GM, Cardiology IT
GE Healthcare
Mr. Jerold Martin, MS
Senior Vice President of Global
Scientific Affairs
Pall Corporation
Mr. Joff Masukawa
President
Diligentia
Innovative Partnerships in Healthcare Executive Roundtable 7
MISSION
The Center for Healthcare Innovation is an independent, 501(c)(3) research and educational institute that helps patients
and providers increase their knowledge and understanding of the opportunities and challenges of maximizing
healthcare value to improve health and quality of life. We aim to make the world a healthier place. CHI encourages and
enables meaningful and executable innovation that aims to address existing and ensuing healthcare dynamics through
communication, education, training, symposia, reports, and research. By bringing the best and brightest healthcare
leaders from all over the world together to share their ideas and expertise, CHI creates a unique opportunity to address
and improve healthcare value, which we view as a function of quality, access, and cost.
OBJECTIVES
1. Bring together key stakeholders to develop collaborative relationships to positively impact healthcare value
2. Increase understanding of the definition, framework, and metrics of healthcare value
3. Produce primary, impactful research focused specifically on the interrelationship of healthcare
quality, access, & costs
4. Analyze fundamental drivers and trends of rapidly rising healthcare costs
5. Identify and disseminate best practices for optimizing healthcare quality and access
INITIATIVES
Diversity, Inclusion, & Life Sciences Symposium
Healthcare Value Executive Roundtable
Patient as an Innovator Educational Workshop
Healthcare Value and the Interrelationship of Quality, Access, and Costs Research Report
Pharmaceutical-ACO Collaboration Research Report
Clinical Trials, Cultural Competency, & Healthcare Access Disparities Research Report
The Value of Sovaldi: Societal Cost Issues of New Interventions on Hepatitis C Research
Unintended Consequences of Healthcare & Life Science Legislation Research Report
Diversity & Inclusion Consulting
The Science Runway: Inspiring Young Girls to Join the Healthcare & Life Sciences Industry
Clinical Research Exchange
7 Understanding Healthcare Value in a Consumer-Oriented, Patient-Centric Era Roundtable
Center for Healthcare Innovation
www.chisite.org